ARAY stock icon

Accuray
ARAY

$1.97
16.57%
 

About: Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Employees: 1,024

0
Funds holding %
of 6,702 funds
Analysts bullish %
0
News positive %
of 7 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

558% more call options, than puts

Call options by funds: $908K | Put options by funds: $138K

2.95% less ownership

Funds ownership: 65.39% [Q4 2023] → 62.44% (-2.95%) [Q1 2024]

9% less funds holding

Funds holding: 127 [Q4 2023] → 116 (-11) [Q1 2024]

15% less capital invested

Capital invested by funds: $180M [Q4 2023] → $153M (-$26.7M) [Q1 2024]

20% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 45

50% less funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 1 (-1) [Q1 2024]

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$9
357%
upside
Avg. target
$9
357%
upside
High target
$9
357%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Roth MKM
Jason Wittes
357%upside
$9
Buy
Initiated
13 Feb 2024

Financial journalist opinion

Based on 7 articles about ARAY published over the past 30 days